International Journal of Clinical Pharmacy

, Volume 38, Issue 2, pp 330–343 | Cite as

Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care

  • Maguy Saffouh El HajjEmail author
  • Hassna Sohil AL-Saeed
  • Maryam Khaja
Research Article


Background Pharmaceutical care (PC) is the philosophy of practice that includes identifying and resolving medication therapy problems to improve patient outcomes. Objectives The study objectives were to examine the extent of pharmaceutical care practice and the barriers to pharmaceutical care provision as perceived by Qatar pharmacists and to assess their level of understanding of pharmaceutical care and their attitudes about pharmaceutical care provision. Setting Qatar pharmacies. Methods A cross sectional survey of all pharmacists in Qatar was made. Consenting pharmacists were given the option to complete the survey either online using an online software or as paper by fax or by hand. Main outcome measures 1. Extent of pharmaceutical care practice in Qatar. 2. Barriers to pharmaceutical care provision in Qatar. 3. Qatar pharmacists’ level of understanding of pharmaceutical care. 4. Qatar pharmacists’ attitudes toward pharmaceutical care provision. Results Over 8 weeks, 274 surveys were collected (34 % response rate). More than 80 % of respondents had correct understanding of the aim of PC and of the pharmacist role in PC. However, only 47 % recognized the patient role in PC and only 35 % were aware of the differences between clinical pharmacy and PC. Yet, more than 80 % believed that they could be advocates when it comes to patients’ medications and health matters. Concerning their practice, respondents reported spending little time on PC activities. Offering feedback to the physician about the patient progress was always or most of the time performed by 21 % of respondents. The top perceived barriers for PC provision included inconvenient access to patient medical information (78 %) and lack of staff and time (77 and 74 % respectively). Conclusions Although PC is not incorporated into pharmacy practice, Qatar pharmacists showed positive attitudes toward PC provision. Further work should focus on improving their PC understanding and on overcoming all barriers.


Pharmaceutical care Pharmacist Qatar 



The study was funded by Qatar University under its undergraduate student research Grant (QUST-CPH-SPR-11/12-4).

Conflicts of interest

Nothing to declare.

Supplementary material

11096_2016_246_MOESM1_ESM.pdf (324 kb)
Supplementary material 1 (PDF 323 kb)


  1. 1.
    Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the patient-centered approach to medication management. McGraw-Hill Medical; 2012. (ISBN-13: 978-0071756389).Google Scholar
  2. 2.
    Odedina FT, Segal R. Behavioral pharmaceutical care scale for measuring pharmacist’s activities. Am J Health Syst Pharm. 1996;53:855–65.PubMedGoogle Scholar
  3. 3.
    Ernst F, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192–9.CrossRefGoogle Scholar
  4. 4.
    Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug related problems. J Clin Pharm Ther. 2009;34:319–27.CrossRefPubMedGoogle Scholar
  6. 6.
    Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;3:CD000336.PubMedGoogle Scholar
  7. 7.
    Jokanovic N, Tan EC, van den Bosch D, Kirkpatrick CM, Dooley MJ, Bell JS. Clinical medication review in Australia: a systematic review. Res Social Adm Pharm. 2015.
  8. 8.
    Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608–22.CrossRefPubMedGoogle Scholar
  9. 9.
    International Pharmaceutical Federation. FIP statement of professional standards pharmaceutical care, 1998.Google Scholar
  10. 10.
    American Society of Health System Pharmacy. ASHP Statement on Pharmaceutical Care, 1993. [cited 1 July 2014]. Available at:
  11. 11.
    Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother. 2006;40:1400–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Bjornsdottir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci. 2010;32:472–87.CrossRefPubMedGoogle Scholar
  13. 13.
    Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm. 2006;63(21):144–50.CrossRefGoogle Scholar
  14. 14.
    Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–30.CrossRefPubMedGoogle Scholar
  16. 16.
    Wibowo Y, Berbatis C, Joyce A, Sunderland VB. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia. Rural Remote Health. 2010;10(3):1400.PubMedGoogle Scholar
  17. 17.
    Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.PubMedGoogle Scholar
  18. 18.
    Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.CrossRefPubMedGoogle Scholar
  19. 19.
    The World Factbook, Qatar, 2015. [cited 13 Oct 2015].
  20. 20.
    Hamad Medical Corporation. Annual Health Report, 2012. [cited 1 July 2014].
  21. 21.
    Qatar Supreme Council of Health. National Health Strategy 2011- 2016, 2014. [cited 1 July 2014].
  22. 22.
    Rossing C, Hansen EH, Krass I. The provision of pharmaceutical care in Denmark: a cross-sectional survey. J Clin Pharm Ther. 2003;28:311–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Ramaswamy-Krishnarajan J, Hill DS. Pharmaceutical care in Canada: an exploratory study of 81 community pharmacies. Can Pharm J/Revue des Pharmaciens du Canada. 2005;138:46–50.CrossRefGoogle Scholar
  24. 24.
    El Hajj M, Kheir N, Zaidan M, Jewesson P. Pharmacist characteristics, medication use perceptions, and professional satisfaction: a first national survey in the state of Qatar. J Healthc Leadersh. 2011;3:9–28.CrossRefGoogle Scholar
  25. 25.
    Roughead L, Semple S, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990–2003, examining effectiveness to improve patient outcomes. Int J Pharm Pract. 2005;13:53–70.CrossRefGoogle Scholar
  26. 26.
    El Hajj MS, Hamid Y. Breast cancer health promotion in Qatar: a survey of community pharmacists’ interests and needs. Int J Clin Pharm. 2011;33(1):70–9.CrossRefPubMedGoogle Scholar
  27. 27.
    El Hajj MS, Al Nakeeb RR, Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists’ attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34(4):667–76.CrossRefPubMedGoogle Scholar
  28. 28.
    Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy. 2004;24(11):1491–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Arifi MN, Al-Dhuwaili AA, Gubara OA, Al-Omar HA, Al-Sultan MS, Saeed RIM. Pharmacists’ understanding and attitudes towards pharmaceutical care in Saudi Arabia. Saudi Pharm J. 2007;15(2):146–59.Google Scholar
  30. 30.
    Oparah AC, Eferakeya AE. Attitudes of Nigerian pharmacists towards pharmaceutical care. Pharm World Sci. 2005;27(3):208–14.CrossRefPubMedGoogle Scholar
  31. 31.
    Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s national pharmacy database project. Int J Pharm Pract. 2007;15(3):185–91.CrossRefGoogle Scholar
  32. 32.
    Brazinha I, Fernandez-Llimos F. Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals. Int J Clin Pharm. 2014;36(5):1031–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Gastelurrutia MA, Faus MJ, Fernández-Llimós F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005;39(12):2105–10.CrossRefPubMedGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2016

Authors and Affiliations

  • Maguy Saffouh El Hajj
    • 1
    Email author
  • Hassna Sohil AL-Saeed
    • 2
  • Maryam Khaja
    • 3
  1. 1.Chair of Clinical Pharmacy and Practice Section, College of PharmacyQatar UniversityDohaQatar
  2. 2.National Center for Cancer Care and Research (NCCCR)Hamad Medical CorporationDohaQatar
  3. 3.Sidra Medical and Research CenterDohaQatar

Personalised recommendations